Empadown Duo Tablet 5/500 mg (Empagliflozin, Metformin Hydrochloride)
Empagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
JW Pharmaceutical Co., Ltd.
MFDS item code 202201341 · Approved 2022.04.04
Improvement of glycemic control in adults with type 2 diabetes mellitus
This drug is used to help control blood sugar in adult patients with type 2 diabetes who also follow dietary and exercise regimens. It is particularly suitable for patients whose blood sugar is not adequately controlled, and additional caution is needed for those with cardiovascular disease. The combination treatment helps improve blood sugar management and is effective for diabetes treatment.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their previous doses of empagliflozin and metformin. When this medicine is used concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take twice the dose at one time; in this case, skip the missed dose. Special Populations Patients with Renal Impairment No dose adjustment is required for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who have no other condition that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily, so treatment should be initiated with the individual single-ingredient products empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, discontinue this medicine immediately (see Precautions for Use, 2. Do not administer to the following patients, item 2)). Elderly Patients In patients aged 75 years or older, consider renal function and the risk of volume depletion.
This drug is used for diabetes treatment, where the two components work together to control blood sugar. There is a risk of a rare side effect known as severe lactic acidosis while taking this drug, so if symptoms occur, consult a doctor immediately. Caution is needed when used with other diabetes medications as hypoglycemia may occur. Patients with significantly reduced kidney function or acute kidney issues, severe infections, or congestive heart failure should not use this drug. Before undergoing tests that use iodine contrast agents, this drug should be temporarily discontinued, and it should be resumed only after kidney function is confirmed to be normal. If scheduled for surgery, discontinue this drug 48 hours prior to the procedure and resume only after confirming normal kidney function post-surgery. Those with poor liver function or excessive alcohol intake should be cautious when using this drug. It is safer for women who are pregnant or breastfeeding not to take this drug. Elderly patients or those with reduced kidney function should have regular kidney function tests and may require dosage adjustments. This drug may increase urinary output, so patients at risk of dehydration or hypotension should closely monitor their fluid status. During treatment, symptoms of genital or urinary tract infections may occur, and appropriate treatment should be sought if symptoms arise. Vitamin B12 levels may decrease, so it is advisable to regularly check vitamin B12 levels during long-term use. Hypoglycemic symptoms may occur, especially when taken with other blood sugar-lowering agents, so blood sugar levels should be carefully monitored. In cases of overdose, serious side effects may occur, so the drug should be taken according to the doctor's instructions for accurate dosing. This drug is not recommended for children or teenagers under 18 years of age. Regular consultations with a physician during treatment are necessary, and any unusual symptoms should be reported to healthcare providers immediately. To store this drug safely, keep it out of the reach of children and store it in its original container.
Not everyone experiences these, and they can vary from person to person.
This drug may be sensitive to air and moisture and should be stored in a tightly sealed container. It is important to maintain storage temperatures between 1 and 30 degrees Celsius. Proper storage will help ensure the drug's effectiveness.
Orange-yellow, oval film-coated tablet with a biconvex shape
10 tablets/box [10 tablets/PTP x 1], 60 tablets/box [10 tablets/PTP x 6], 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Empagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
JW Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.